Percutaneous Tibial Nerve Stimulation Beneficial for Overactive Bladder

Improvement seen in overactive bladder symptoms of urinary urgency, nocturia, incontinence, and frequency after 12 weeks of PTNS
bladderAdobe Stock
Medically Reviewed By:
Mark Arredondo, M.D.

THURSDAY, June 29, 2023 (HealthDay News) -- For women with overactive bladder (OAB), percutaneous tibial nerve stimulation (PTNS) is associated with improvement of symptoms, according to a study published online May 16 in the Journal of Clinical Medicine.

Connor McPhail, from FBW Gynaecology Plus in Adelaide, Australia, and colleagues conducted a prospective cohort study to examine the long-term efficacy of PTNS treatment for OAB. Women with OAB received PTNS once per week for 12 weeks in phase 1 and then received 12 PTNS treatments over six months in phase 2. A total of 166 women were included in phase 1 and 51 completed phase 2.

The researchers found that compared to baseline, there was a significant reduction in urinary urgency, nocturia, incontinence, and frequency (improvements of 29.8, 29.8, 31.0, and 33.8 percent, respectively). A significant reduction in urinary frequency (improvement of 56.5 percent) was also seen for patients who completed phase 2.

"This study should promote future investigation into the long-term maintenance of the therapeutic benefit of PTNS in the Australian setting, particularly looking at patient demographics to find out who experienced symptomatic improvements, and possibly a comparative study between the benefits and cost of PTNS and surgical treatments, such as intradetrusor injections," the authors write.

Abstract/Full Text

Related Stories

No stories found.